Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LYRA Lyra Therapeutics	$0.60 +2.9%	$0.70	$0.31 ▼ $9.95	$1.04M	0.7	58,034 shs	355 shs
NUWE Nuwellis	$3.30 -0.3%	$25.10	$2.88 ▼ $908.25	$254K	0.18	5.38 million shs	788,255 shs
PFSA Profusa	$0.11 -3.1%	$0.39	$0.11 ▼ $180.00	$550K	0.35	7.15 million shs	1.53 million shs
SSKN Strata Skin Sciences	$0.13	$0.14	$0.11 ▼ $3.86	$771K	-0.06	233,210 shs	324 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LYRA Lyra Therapeutics	+2.92%	-11.76%	-23.08%	+22.40%	-95.12%
NUWE Nuwellis	-0.33%	-29.37%	-87.56%	-91.02%	-99.12%
PFSA Profusa	-3.05%	-36.44%	-69.12%	-75.90%	+11,439,900.00%
SSKN Strata Skin Sciences	0.00%	-4.38%	-6.43%	-49.62%	-94.30%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LYRA Lyra Therapeutics	$0.60 +2.9%	$0.70	$0.31 ▼ $9.95	$1.04M	0.7	58,034 shs	355 shs
NUWE Nuwellis	$3.30 -0.3%	$25.10	$2.88 ▼ $908.25	$254K	0.18	5.38 million shs	788,255 shs
PFSA Profusa	$0.11 -3.1%	$0.39	$0.11 ▼ $180.00	$550K	0.35	7.15 million shs	1.53 million shs
SSKN Strata Skin Sciences	$0.13	$0.14	$0.11 ▼ $3.86	$771K	-0.06	233,210 shs	324 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LYRA Lyra Therapeutics	+2.92%	-11.76%	-23.08%	+22.40%	-95.12%
NUWE Nuwellis	-0.33%	-29.37%	-87.56%	-91.02%	-99.12%
PFSA Profusa	-3.05%	-36.44%	-69.12%	-75.90%	+11,439,900.00%
SSKN Strata Skin Sciences	0.00%	-4.38%	-6.43%	-49.62%	-94.30%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LYRA Lyra Therapeutics	1.50	Reduce	N/A	N/A
NUWE Nuwellis	1.00	Sell	N/A	N/A
PFSA Profusa	1.00	Sell	N/A	N/A
SSKN Strata Skin Sciences	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest NUWE, LYRA, SSKN, and PFSA Analyst Ratings

Date	Company	Brokerage	Action	Rating
6/24/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
3/27/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
3/27/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 6/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LYRA Lyra Therapeutics	$600K	1.78	N/A	N/A	$8.86 per share	0.07
NUWE Nuwellis	$8.77M	1.01	N/A	N/A	$1.58 per share	2.09
PFSA Profusa	N/A	N/A	N/A	N/A	($21.69) per share	N/A
SSKN Strata Skin Sciences	$30.98M	0.02	N/A	N/A	$1.19 per share	0.11

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LYRA Lyra Therapeutics	-$93.43M	-$19.15	N/A	N/A	N/A	-5,491.17%	-1,010.91%	-58.92%	N/A
NUWE Nuwellis	-$17.52M	-$64.02	N/A	N/A	N/A	-214.90%	-32,351.83%	-249.08%	8/13/2026 (Estimated)
PFSA Profusa	-$35.82M	-$169.72	N/A	N/A	N/A	N/A	N/A	-1,348.07%	N/A
SSKN Strata Skin Sciences	-$10.09M	-$1.41	N/A	N/A	N/A	-35.64%	-476.73%	-33.49%	8/19/2026 (Estimated)

Latest NUWE, LYRA, SSKN, and PFSA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/15/2026	Q1 2026	PFSA Profusa	N/A	-$2.05	N/A	-$2.05	N/A	N/A
5/12/2026	Q1 2026	NUWE Nuwellis	-$35.00	-$73.15	-$38.15	-$2.19	$2.09 million	$2.40 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
LYRA Lyra Therapeutics	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
PFSA Profusa	N/A	N/A	N/A	N/A	N/A
SSKN Strata Skin Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LYRA Lyra Therapeutics	N/A	2.43	2.43
NUWE Nuwellis	N/A	1.56	1.09
PFSA Profusa	N/A	0.02	0.02
SSKN Strata Skin Sciences	10.22	0.95	0.75

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LYRA Lyra Therapeutics	95.62%
NUWE Nuwellis	3.13%
PFSA Profusa	9.81%
SSKN Strata Skin Sciences	32.43%

Insider Ownership

Company	Insider Ownership
LYRA Lyra Therapeutics	3.25%
NUWE Nuwellis	1.60%
PFSA Profusa	0.76%
SSKN Strata Skin Sciences	40.92%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LYRA Lyra Therapeutics	50	1.78 million	1.72 million	No Data
NUWE Nuwellis	70	2.68 million	2.64 million	Not Optionable
PFSA Profusa	2	4.66 million	4.63 million	N/A
SSKN Strata Skin Sciences	120	5.89 million	3.48 million	Not Optionable

NUWE, LYRA, SSKN, and PFSA Headlines

Recent News About These Companies

New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo

May 18, 2026 | globenewswire.com

STRATA Skin Sciences Confirms Nasdaq Delisting

February 19, 2026 | globenewswire.com

SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy

February 18, 2026 | zacks.com

STRATA cites study supporting 308 nm laser for psoriasis

February 18, 2026 | msn.com

Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

February 18, 2026 | globenewswire.com

STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis

February 17, 2026 | globenewswire.com

STRATA Skin Sciences stock plunges after Nasdaq delisting notice

February 12, 2026 | in.investing.com

Strata Skin Sciences to Delist and Go Dark

February 11, 2026 | tipranks.com

Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences

February 11, 2026 | globenewswire.com

Strata Skin Sciences showcases XTRAC, TheraclearX at TeraCILAD 2025

December 10, 2025 | msn.com

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico

December 9, 2025 | globenewswire.com

Strata Skin Sciences Inc (SSKN) Q3 2025 Earnings Call Highlights: Navigating Challenges and ...

November 16, 2025 | finance.yahoo.com

STRATA Skin Sciences Reports Q3 2025 Financial Results

November 14, 2025 | msn.com

Strata Skin Sciences Reports Q3 2025 Revenue Decline

November 13, 2025 | msn.com

STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript

November 13, 2025 | seekingalpha.com

STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

November 13, 2025 | markets.businessinsider.com

STRATA Skin Sciences to Report Q3 Results and Host Investor Call November 13

November 13, 2025 | msn.com

A Peek at Strata Skin Sciences's Future Earnings

November 13, 2025 | benzinga.com

Strata Skin Sciences announces CMS recognition of expanded CPT codes

November 6, 2025 | msn.com

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption ...

November 6, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, LYRA, SSKN, and PFSA Company Descriptions

Lyra Therapeutics NASDAQ:LYRA

$0.60 +0.02 (+2.92%)

As of 06/26/2026 02:03 PM Eastern

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Nuwellis NASDAQ:NUWE

$3.30 -0.01 (-0.33%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$3.30 0.00 (-0.15%)

As of 06/26/2026 07:59 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Profusa NASDAQ:PFSA

$0.11 0.00 (-3.05%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$0.11 0.00 (-1.22%)

As of 06/26/2026 07:50 PM Eastern

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

Strata Skin Sciences NASDAQ:SSKN

$0.13 0.00 (0.00%)

As of 06/25/2026 03:56 PM Eastern

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, LYRA, SSKN, and PFSA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, LYRA, SSKN, and PFSA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, LYRA, SSKN, and PFSA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, LYRA, SSKN, and PFSA Company Descriptions

Lyra Therapeutics NASDAQ:LYRA

Nuwellis NASDAQ:NUWE

Profusa NASDAQ:PFSA

Strata Skin Sciences NASDAQ:SSKN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, LYRA, SSKN, and PFSA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, LYRA, SSKN, and PFSA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, LYRA, SSKN, and PFSA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, LYRA, SSKN, and PFSA Company Descriptions

Lyra Therapeutics NASDAQ:LYRA

Nuwellis NASDAQ:NUWE

Profusa NASDAQ:PFSA

Strata Skin Sciences NASDAQ:SSKN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools